Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BDSI
4976
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $173K | ﹤0.01% |
41,254
-16,896
| -29% | -$72.2K |
|
4977
FRP Holdings
FRPH
$436M
| $172K | ﹤0.01% |
7,144
-2,254
| -24% | -$56.2K |
|
4978
PUT
SL Green Realty
SLG
$3.84B
| $172K | ﹤0.01% |
2,169
+1,033
| +91% | +$80.4K |
|
4979
CALL
Snap-on
SNA
$21.4B
| $172K | ﹤0.01% |
1,100
-200
| -15% | -$30.7K |
|
4980
Vishay Precision Group
VPG
$1.26B
| $172K | ﹤0.01% |
5,270
-1,453
| -22% | -$51.9K |
|
4981
CALL
Buckle
BKE
$2.32B
| $171K | ﹤0.01% |
8,300
+1,100
| +15% | +$21.1K |
|
4982
Global Indemnity Group
GBLI
$400M
| $171K | ﹤0.01% |
6,851
+1,403
| +26% | +$37.9K |
|
4983
CALL
Gentex
GNTX
$5.03B
| $171K | ﹤0.01% |
6,200
-3,700
| -37% | -$97.8K |
|
4984
Ocular Therapeutix
OCUL
$1.83B
| $171K | ﹤0.01% |
56,197
-9,566
| -15% | -$42.8K |
|
|
TECX
4985
Tectonic Therapeutic
TECX
$527M
| $171K | ﹤0.01% |
1,008
-142
| -12% | -$32.1K |
|
|
ATCO
4986
CALL
DELISTED
Atlas Corp.
ATCO
| $171K | ﹤0.01% |
16,100
+10,500
| +188% | +$109K |
|
4987
Angi Inc
ANGI
$239M
| $170K | ﹤0.01% |
2,399
+1,338
| +126% | +$137K |
|
|
CIM
4988
PUT
Chimera Investment
CIM
$1.06B
| $170K | ﹤0.01% |
2,900
+2,500
| +625% | +$146K |
|
4989
Intrepid Potash
IPI
$450M
| $170K | ﹤0.01% |
5,212
-1,132
| -18% | -$37.8K |
|
4990
PUT
Upbound Group
UPBD
$1.15B
| $170K | ﹤0.01% |
6,600
+1,600
| +32% | +$42K |
|
|
PVLA
4991
Palvella Therapeutics
PVLA
$2.03B
| $170K | ﹤0.01% |
621
-41
| -6% | -$15.9K |
|
4992
Civista Bancshares
CIVB
$608M
| $169K | ﹤0.01% |
7,784
-2,424
| -24% | -$51.9K |
|
4993
CALL
SBA Communications
SBAC
$19.1B
| $169K | ﹤0.01% |
700
-300
| -30% | -$74.2K |
|
4994
Ecopetrol
EC
$34.1B
| $168K | ﹤0.01% |
9,887
-40,169
| -80% | -$696K |
|
4995
CALL
Manitowoc
MTW
$513M
| $168K | ﹤0.01% |
13,400
+800
| +6% | +$12.1K |
|
4996
Old Republic International
ORI
$10.5B
| $168K | ﹤0.01% |
7,159
-207,951
| -97% | -$4.75M |
|
4997
Hudbay
HBM
$10.3B
| $167K | ﹤0.01% |
46,300
-6,600
| -12% | -$26.9K |
|
4998
MediciNova
MNOV
$65.5M
| $167K | ﹤0.01% |
20,998
-5,546
| -21% | -$49.4K |
|
4999
Star Bulk Carriers
SBLK
$3.21B
| $166K | ﹤0.01% |
16,503
+15,199
| +1,166% | +$155K |
|
5000
XBiotech
XBIT
$67.7M
| $166K | ﹤0.01% |
15,905
+1,728
| +12% | +$14.1K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.